- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Camurus
Market Cap: SEK 31.5b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 526.50
7D
0.2%
1Y
2.9%
Swedish Orphan Biovitrum
Market Cap: SEK 152.9b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 442.20
7D
0.2%
1Y
50.8%
Vitrolife
Market Cap: SEK 13.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 98.90
7D
-7.4%
1Y
-36.3%
Bonesupport Holding
Market Cap: SEK 15.1b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 229.80
7D
-10.5%
1Y
-9.6%